correction to lancet infect dis 2019; published online april 20. https://doi.org/10.1016/s1473-3099(20)30160-2 (the lancet infectious diseases, (s1473309920301602), (10.1016/s1473-3099(20)30160-2). ¬© 2020 Elsevier LtdFolegatti PM, Bittaye M, Flaxman A, et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis 2020; published online April 20. https://doi.org/10.1016/S1473-3099(20)30160-2‚ÄîIn this Article, the y-axis label for Figure 2B should be ‚ÄúIgG titre (ELISA units)‚Äù, and in Figure 3 the lower limit of detection represented by the dashed line for the England-1 pseudovirus should be 3. These corrections have been made to the online version as of May 12, 2020, and will be made to the printed version.